# Active work: Mizan loss diagnosis and TimesFM suitability

STATUS: ACTIVE
OWNER: Codex root with read-only research delegates
TOOL: Codex
STARTED_UTC: 2026-09-10
STARTING_REVISION: 35ef1f1552e0c66d4050466f1023f35023733f33
WORKTREE_OR_BRANCH: D:\quant_system on main (shared checkout; unique documentation only)

## Objective

Explain current losses in both Mizan virtual books from ledger and strategy evidence; assess the official google/timesfm-3.0-pytorch release for a research challenger.

## Owned paths

- agent_context/work/active/20260910-codex-mizan-loss-diagnosis.md
- agent_context/work/completed/20260910-codex-mizan-loss-diagnosis.md
- reports/mizan_loss_diagnosis_20260910.md

## Non-goals

- No strategy, source, tests, configuration, portfolio, evidence, scheduled task, or dependency changes.
- No retraining, holdout consumption, broker order calls, model installation, or promotion.
- No changes to another agent's files or workspaces. Read-only delegates own no code paths.

## Plan

1. Read startup context, claims, status and workspaces.
2. Reconcile paper-book snapshots and trace strategy/training behavior.
3. Verify TimesFM through primary sources.
4. Produce source-linked diagnosis, run required audits, retire record.

## Current step

Startup complete; inspecting runtime snapshots and current strategy code.

## Decision rationale

User requested diagnosis and suitability advice, not an implementation. Current records and runtime outputs need verification because historical context predates both paper books. Preserve running research and existing claims.

## Commands and outcomes

- Startup context and every active record read; claims remain live.
- git status: six modified market-cache JSON files, many new market-cache datasets and ensure_xs_watch.ps1 are pre-existing foreign work; not edited.
- git worktree list / branch --list: main plus two Codex worktrees and ci-workflow-pending; left unchanged.

## Files changed

- This unique work record only so far.

## Blockers and conflicts

Source and runtime paths are actively claimed; analysis is read-only. No blocker to diagnosis.

## Stop point

No strategy or runtime mutation. No staging or commits.

## Next safe action

Measure both current paper-book states and trace their P&L and training lineage.
